Sign in
India
United Kingdom
United States
Australia
Canada
Germany
Singapore
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Type here...
Search
Instagram
Linkedin
Twitter
Friday, February 21, 2025
20.1
C
Delhi
India
United Kingdom
United States
Australia
Canada
Germany
Singapore
More
type here...
Search
India
United Kingdom
United States
Australia
Canada
Germany
Singapore
type here...
Search
Tag:
HUTCHMED
HUTCHMED Announces NMPA Full Approval for ORPATHYS ® ( savolitinib) in China for Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC –...
Business
Business Journal
-
January 14, 2025
This web site aggregates information articles from varied sources for informational functions. We don't declare possession of the...
HUTCHMED Announces US$ 608 million Divestment of Non-Core Joint Venture – London Stock Exchange News Today
Business
Business Journal
-
January 1, 2025
This web site aggregates information articles from numerous sources for informational functions. We don't declare possession of the...
HUTCHMED Announces Launch by Takeda of FRUZAQLA ® (fruquintinib) in Japan – London Stock Exchange News Today
Business
Business Journal
-
November 22, 2024
This web site aggregates information articles from varied sources for informational functions. We don't declare possession of the...
HUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2024 and the 2024 World Conference of Lung Cancer – London Stock Exchange News...
Business
Business Journal
-
September 9, 2024
This web site aggregates information articles from numerous sources for informational functions. We don't declare possession of the...
HUTCHMED Provides Update on Fruquintinib for Second-Line Gastric Cancer in China – London Stock Exchange News Today
Business
Business Journal
-
August 30, 2024
This web site aggregates information articles from varied sources for informational functions. We don't declare possession of the...